TrialNature medicine2025

Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial.

Sabine E Breukers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.